Award
NIH Reporter #1R01DK142340-01A1
Identifying Collaborating Factors Driving DDX41 Mutant Pathology in MDS
Recipient
Not specified
Award Amount
$829,319.00
Ceiling
$829,319.00
Awarded
January 26, 2026
Identifier
1R01DK142340-01A1
Research project funded by NIDDK focusing on DDX41 mutant pathology in myelodysplastic syndromes, awarded $829,319 for the period 2026-2030.
Description
This project involves research on germline mutations in DDX41 related to myelodysplastic syndromes, with a focus on aging and inflammation. The award amount is approximately $829,319, with a project duration from February 2026 to November 2030. The funding agency is the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).